EPHA4 and amyotrophic lateral sclerosis: The aims of this study were to test whether such a potential therapeutic reagent would exert a protective effect on ALS progression in a commonly used model of ALS, the SOD1G93A mouse model, and to determine how EphA4 modifies the progression of ALS.